CME Group Target of Unusually Large Options Trading (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) was the recipient of unusually large options trading on Wednesday. Stock traders purchased 8,099 call options on the company. This is an increase of 129% compared to the average volume of 3,537 call options.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group beat Q2 estimates, reporting $2.99 EPS versus $2.91 expected and revenue of about $1.71 billion versus $1.68 billion expected, supporting the stock. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which likely boosted investor confidence. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Record market data revenue and strong trading volumes suggested core business momentum remains healthy, another bullish catalyst for the stock. CME Group jumps after Q2 earnings beat and strong trading activity
• Neutral Sentiment: UBS reiterated a Hold rating with a $260 target, signaling solid fundamentals but limited upside from current levels. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
• Negative Sentiment: JPMorgan kept an Underweight rating and BofA maintained an Underperform stance, both implying analysts still see downside risk despite the earnings beat. Benzinga report on JPMorgan price target change Benzinga report on Bank of America price target change

Analyst Upgrades and Downgrades

CME has been the topic of several research reports. UBS Group dropped their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Barclays reduced their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a research report on Thursday, June 18th. Morgan Stanley boosted their target price on CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, TD Cowen reduced their target price on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Eleven analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $291.81.

Insider Buying and Selling

In other news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William R. Shepard bought 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On CME Group

Several hedge funds have recently bought and sold shares of the business. Whipplewood Advisors LLC increased its holdings in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the period. Asset Dedication LLC lifted its position in shares of CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $27,000. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the fourth quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $28,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 2.0%

Shares of NASDAQ:CME opened at $254.32 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $92.16 billion, a PE ratio of 21.57, a price-to-earnings-growth ratio of 3.10 and a beta of 0.25. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16. The firm has a 50 day simple moving average of $255.00 and a 200 day simple moving average of $281.41.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business posted $2.96 EPS. The company’s revenue was up .8% on a year-over-year basis. As a group, research analysts expect that CME Group will post 12.17 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.